We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$243M
AUM Growth
-$2.1M
Cap. Flow
-$15.4M
Cap. Flow %
-6.33%
Top 10 Hldgs %
78.49%
Holding
71
New
3
Increased
8
Reduced
27
Closed
26

Top Sells

Rank Stock Value
1
IBRX icon
ImmunityBio
IBRX
+$2.66M
2
BDX icon
Becton Dickinson
BDX
+$2.16M
3
ARE icon
Alexandria Real Estate Equities
ARE
+$1.15M
4
RMD icon
ResMed
RMD
+$1.02M
5
BIIB icon
Biogen
BIIB
+$881K

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.95%
2 Healthcare 11.05%
3 Consumer Discretionary 0%
4 Consumer Staples 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNDF icon
26
Schwab Fundamental International Large Company Index ETF
FNDF
$26B
$957K 0.39%
37,966
+5,076
+15% +$125K
SCHE icon
27
Schwab Emerging Markets Equity ETF
SCHE
$13B
$700K 0.29%
30,369
+307
+1% +$6.93K
VDE icon
28
Vanguard Energy ETF
VDE
$10.7B
$605K 0.25%
6,198
-110
-2% -$10.4K
VGK icon
29
Vanguard FTSE Europe ETF
VGK
$30.9B
$579K 0.24%
11,884
-16,861
-59% -$811K
EWJ icon
30
iShares MSCI Japan ETF
EWJ
$22.7B
$552K 0.23%
11,024
-6,487
-37% -$316K
RLY icon
31
State Street Multi-Asset Real Return ETF
RLY
$1.35B
$495K 0.2%
20,130
MLPX icon
32
Global X MLP & Energy Infrastructure ETF
MLPX
$3.63B
$494K 0.2%
10,834
DSI icon
33
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$464K 0.19%
11,536
-372
-3% -$14.9K
AAXJ icon
34
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
$444K 0.18%
7,331
-841
-10% -$49.2K
CMBS icon
35
iShares CMBS ETF
CMBS
$472M
$420K 0.17%
7,910
EBND icon
36
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$383K 0.16%
13,503
DXJ icon
37
WisdomTree Japan Hedged Equity Fund
DXJ
$7.34B
$362K 0.15%
8,428
-1,164
-12% -$48.4K
ALR
38
DELISTED
Alere Inc
ALR
$307K 0.13%
+7,100
New +$290K
EWC icon
39
iShares MSCI Canada ETF
EWC
$6.85B
$269K 0.11%
10,458
-4,564
-30% -$116K
VWO icon
40
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$257K 0.11%
6,832
IWB icon
41
iShares Russell 1000 ETF
IWB
$49.1B
$252K 0.1%
+2,090
New +$251K
IVV icon
42
iShares Core S&P 500 ETF
IVV
$898B
$222K 0.09%
1,020
DLN icon
43
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
$208K 0.09%
5,410
-1,462
-21% -$56.5K
ZSAN
44
DELISTED
Zosano Pharma Corporation
ZSAN
$13K 0.01%
+24
New +$19.1K
AGIO icon
45
Agios Pharmaceuticals
AGIO
$1.99B
-10,000
Closed -$419K
ARE icon
46
Alexandria Real Estate Equities
ARE
$8.87B
-11,108
Closed -$1.15M
ASRT
47
DELISTED
Assertio
ASRT
-178
Closed -$210K
BAC icon
48
Bank of America
BAC
$436B
-10,009
Closed -$133K
BDX icon
49
Becton Dickinson
BDX
$51.6B
-13,059
Closed -$2.16M
BIIB icon
50
Biogen
BIIB
$32.3B
-3,644
Closed -$881K

Similar funds

Callan Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Callan Capital held 71 positions worth $243M, down 0.86% from $245M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Callan Capital withdrew a net $15.4M in Q3 2016, closing 26 positions and reducing 27 holdings. Its most notable exit was Becton Dickinson, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 86% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Callan Capital opened a new position in Alere Inc worth $307K.

  • Callan Capital's largest Q3 2016 buy was Alere Inc: 7,100 shares worth $307K.
  • Callan Capital added most to Vanguard FTSE All-World ex-US ETF in Q3 2016, an estimated $701K increase.
  • Callan Capital's biggest Q3 2016 reduction was ImmunityBio, cutting an estimated $2.66M.
  • Callan Capital fully exited Becton Dickinson in Q3 2016, selling an estimated $2.16M.
  • Callan Capital's ten largest holdings make up 78% of its $243M portfolio in Q3 2016.
  • Callan Capital opened 3 new positions and closed 26 in Q3 2016.
  • Callan Capital's portfolio value fell 0.86% quarter-over-quarter to $243M.

Based on Callan Capital's 13F filing for Q3 2016, filed 15 Nov 2016.